Publications by authors named "Peter Dull"

Claim this Profile
H
Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT).
Mónica S Sierra, Loretto J Carvajal, Peter Dull, Rolando Herrero, John Schussler

Vaccine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting summary: Global vaccine and immunization research forum, 2023.
Birgitte Giersing, Annie X Mo, Angela Hwang, Shahida Baqar, Kristen Earle, Peter Dull

Vaccine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
Peter M Dull, Sharon L Achilles, Rafi Ahmed, Ruanne V Barnabas, Nicole G Campos

Vaccine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose human papillomavirus vaccination: an update.
Aimée R Kreimer, Deborah Watson-Jones, Jane J Kim, Peter Dull

J Natl Cancer Inst Monogr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus prophylactic vaccines: update on new vaccine development and implications for single-dose policy.
Anne E Schuind, Kanduri Ananth Balaji, Anna Du, Yuan Yuan, Peter Dull

J Natl Cancer Inst Monogr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop.
Anne E Schuind, Helen Rees, John Schiller, Nelly Mugo, Peter Dull

Prev Med Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
Andrew Ford, Angela Hwang, Annie X Mo, Shahida Baqar, Nancy Touchette, Peter Dull

Vaccine· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
Holly J Prudden, Sharon L Achilles, Celina Schocken, Nathalie Broutet, Karen Canfell, Peter Dull

Vaccine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a population-based threshold of protection for COVID-19 vaccines.
David Goldblatt, Andrew Fiore-Gartland, Marina Johnson, Adam Hunt, Christopher Bengt, Peter Dull

Vaccine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Kristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, David Goldblatt, Peter B Gilbert, Peter Dull

Vaccine· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHO International Standard for anti-SARS-CoV-2 immunoglobulin.
Paul A Kristiansen, Mark Page, Valentina Bernasconi, Giada Mattiuzzo, Peter Dull

Lancet· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis.
Andrew M Secor, Matthew Driver, Brenda Kharono, Dianna Hergott, Gui Liu, Peter Dull

Vaccines (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis.
Darrell H S Tan, Rupesh Agrawal, Ruanne V Barnabas, Jon T Giles, Peter Dull

Trials· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting report: Global vaccine and immunization research forum, 2018.
Peter Dull, Martin Friede, Angela Hwang, B Fenton Hall

Vaccine· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development.
Fikri Avci, Francesco Berti, Peter Dull, John Hennessey, Viliam Pavliak

mSphere· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital readmission in persons with dementia: A systematic review.
Chenjuan Ma, Silin Bao, Peter Dull, Bei Wu, Fang Yu

Int J Geriatr Psychiatry· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
Margaret Stanley, Peter Dull

Vaccine· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination vaccine strategies to prevent enteric infections.
Richard Walker, Peter Dull

Vaccine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
Shabir A Madhi, Anthonet Koen, Clare L Cutland, Lisa Jose, Niresha Govender, Peter M Dull

Clin Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402].
Mildred A Iro, Matthew D Snape, Merryn Voysey, Sena Jawad, Adam Finn, Peter Dull

Vaccine· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine.
Robert C Read, Peter Dull, Xilian Bai, Kate Nolan, Jamie Findlow

Vaccine· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial.
Mildred A Iro, Matthew D Snape, Merryn Voysey, Sena Jawad, Adam Finn, Peter Dull

Vaccine· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response.
Scott M Berry, Elizabeth A Petzold, Peter Dull, Nathan M Thielman, Coleen K Cunningham

Clin Trials· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
Shabir A Madhi, Clare L Cutland, Lisa Jose, Anthonet Koen, Niresha Govender, Peter M Dull

Lancet Infect Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial.
Gilbert G G Donders, Scott A Halperin, Roland Devlieger, Sherryl Baker, Pietro Forte, Peter M Dull

Obstet Gynecol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis